Serum miR-200c and miR-371-5p as the Useful Diagnostic Biomarkers and Therapeutic Targets in Kawasaki Disease

Figure 1

The expression of serum miR-200c and miR-371-5p in KD patients and healthy controls; Control: healthy controls; KD: Kawasaki disease; Good-IVIG: KD patients with a good response to IVIG therapy; No-IVIG: KD patients with no response to IVIG therapy; No-PE: KD patients not needing plasma exchange; PE: KD patients needing plasma exchange; P value < 0.01, unpaired t-test.

(a)

(b)

(c)

(d)

(e)

(f)